Search

everythinglearnresearchcommunity

for

Search:↓

Botulinum toxin injections may help treat hair loss by blocking harmful secretion in hair follicles.

Minoxidil tretinoin liposomal based hydrogel shows promise for effective treatment of hair loss by delivering both drugs at the same time.

PRP therapy improves hair density and thickness in AGA patients, even with other treatments.

Finasteride and dutasteride increase sexual dysfunction risk by 1.57 times in male hair loss treatment.

FDA-cleared devices may help treat hair loss, but more research needed; consult dermatologist before use.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

Botanicals like green tea extract show potential for hair growth, but more research is needed.

No clear link between hair loss and metabolic syndrome, but some differences in blood pressure and glucose levels.

The X5 Hairlaser might help treat male hair loss, but more research is needed.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

Balding men have higher heart disease risk.

Minoxidil, finasteride, and hair transplantation combined give best results for hair loss.

Gene differences may affect baldness treatment response in Korean men.

Hairless gene not strongly linked to baldness.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

Minoxidil and finasteride work best for hair loss; more research needed.

Women with AGA have higher lipid levels, increasing heart disease risk.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Finasteride side effects in young men may be linked to specific gene variations.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

The T-zone on the face has more androgen receptors and produces more oil than the U-zone.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Estrogen and prolactin may play bigger roles in female hair loss than previously thought.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Antiandrogen therapy helps treat genetic hair loss.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.